Announcement:

The results of a recent collaboration between Sanofi, GSK, Lilly, Vesalius Therapeutics, Leiden University, Heidelberg University, ElmorePathology and Newcells aimed at enhancing safety assessments has just been published. Find out how rat kidney gene co-expression networks has enabled biomarker identification and human translation for renal safety assessments.

Find out more

Home › Resources › Videos and webinars › Human Induced Pluripotent Stem Cell (hiPSC)-derived Retinal Model Containing Microglial Cells

Human Induced Pluripotent Stem Cell (hiPSC)-derived Retinal Model Containing Microglial Cells

Dr Valeria Chichagova (Chief Scientific Officer at Newcells) gives a presentation on her poster: “Human Induced Pluripotent Stem Cell (hiPSC)-derived Retinal Model Containing Microglial Cells”.

Date: Friday 17th April 2020

Published

April 18, 2020

Published by

Dr Valeria Chichagova

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View Today

Please enter the required details to view the webinar. You are not automatically signing up for receiving marketing emails.

Book a Call